A patient with methicillin-resistant Staphylococcus aureus bacteremia received vancomycin (MIC = 0.8 ,ug/ml, MBC = 15 ,ug/ml) and heparin simultaneously through the same intravenous line to treat a septic deep venous thrombosis. Bacteremia persisted for 7 days. Bacteremia terminated when the simultaneous inftsion of heparin and vancomycin through the same line was stopped. This 
Among the causes of persistent or breakthrough bacteremia are a removable focus of infection, an incorrect choice or dosage of antibiotics, an undrained abscess, and an incorrect mode of drug administration. A case of persistent staphylococcal bacteremia was observed at our hospital. Persistence of the organism may have resulted from antibiotic inactivation because of simultaneous administration of heparin and vancomycin through the same intravenous line. This may have caused a chemical or physical reaction that resulted in some nullification of the antibacterial activity of vancomycin. This phenomenon has not been described previously for vancomycin and heparin, but Ragamey et al. have described decreased aminoglycoside activity when gentamicin was exposed to heparin in blood-sampling tubes (6) . Vancomycin and heparin are known to be incompatible, probably because of a concentration-dependent acid-base reaction causing a precipitate in material (8) completing a 4-week course of vancomycin and was ultimately lost to follow-up.
MATERIALS AND METHODS
The presumed alteration in the activity of vancomycin by heparin was tested by dissolving vancomycin in 250 nil of 5% dextrose to yield a concentration of 4 mg/ml; heparin was mixed with 1 liter of 5% dextrose solution to yield a concentration of 25 U/ml. These concentrations were equivalent to those in the intravenous line when vancomycin and heparin were administered to the patient sinmultaneously. A solution of vancomycin (4 mg/ml) Alone and a solution of heparin (25 mg/ml) plus vancomycin (4 mg/ml) were immediately diluted serially with human serum (AB positive) to provide various concentrations of each drug within the range of a bioassay systenm. The final calculated vancomycin concentrations ranged from 2.5 ,uglml to 100 ug/tnl, and the final heparin concentrations ranged from 0.01 to 0.625 U/ml. Serum was used to simulate the conditions when a mixture of vancomycin and heparin is infused intravenously. Aliquots (20-,uI) of the various dilutions were added to standard diffusion disks, which were dropped onto agar (antibiotic medium 5; Difco Laboratories, Detroit, Mich.) that had been inoculated with Bacillus subtilis. After plates were incubated for 4 h at 35°C, zone diameters were measured and compared with the zones around known concentrations of vancomycin (1) .
When administered through separate intravenous lines, high concentrations of vancomycin and heparin do not mix. Each drUg is diluted within the intravascular space to much lower concentrations before their contact. Gradient plates were prepared for an assay of the vancomycin activity of the solutions that were initially prepared at these lower concentrations (2 to 25 ,ug/ml) expected in the serum of patients (7) . Vancomycin, at concentrations of 2, 4, 5, 6, and 25 ,ug/ml, was mixed with heparin at a concentration of 0.5 U/ml, added to Mueller-Hinton agar, poured into inclined square plates, and allowed to harden. This mixture was prepared from solutions that were not permitted to mix at high concentrations. After returning plates to a horizontal position, plain Mueller-Hinton agar was added to level offthe top of each plate. Similar plates were prepared without heparin. Overnight broth cultures of three methicillin-resistant S. aureus strains (vancomycin MICs and MBCs were 1.6 and 1.6, 3.1 and 3.1, and 6.25 and 6.25 respectively) were streaked with a cotton-tipped applicator in the axis of the concentration gradient and inicubated at 35°C overnight. The physical length of the colony growth was measured and compared with the length of colonies in similar plates containing vancomycin alone. The MIC and MBC for all organisms were determined by the microtiter technique described by Harwick et al. (4) .
RESULTS
When the mixture of high concentrations of vancomycin ( A concentrations, showed no reduction in bioactivity (Table   1 ).
In contrast, the gradient plate assay showed no significant difference between the antibacterial effects of vancomycin alone in agar and of vancomycin mixed with heparin at much lower initial concentrations (2 to 25 ,ug/ml and 0.5 U/ml, respectively) (Fig. 2) . Therefore, there was no observed effect of heparin on the bioactivity of vancomycin when the mixture was initially prepared at the concentrations expected in serum after infusion of the two drugs through separate intravenous lines.
At the higher concentrations that probably occur in intravenous tubing when the two drugs are infused simultaneously (1 to 5 mg of vancomycin per ml and 1 to 1,000 U of heparin per ml), a white precipitate was immediately noted in tubes containing both vancomycin and heparin. On the other hand, at concentrations attainable in serum (vancomycin at 5, 50, and 100 ,ug/ml and heparin at less than 1 U/ml), no precipitates formed.
DISCUSSION
The staphylococcal bacteremia persisting for 7 days in this patient was unusual and was presumably caused by inactivation of vancomycin by heparin in mixtures of the two agents in a single intravenous line. Korzeniowsky and Sande report that the mean duration of methicillin-susceptible staphylococcal bacteremia is 3 days (±1 day) in addicts with right-sided endocarditis treated with nafcillin and gentamicin (5) . The diminished activity of vancomycin coupled with the relatively high MBC (tolerance) for this isolate may have prevented in vivo killing of the organism. Typical peak concentrations of vancomycin in serum after a 1-g intravenous dose are between 20 and 50 ,ug/ml (2). However, if a 50 to 60% reduction in the bioactivity of vancomycin occurs after reacting with heparin, the net bioactive vancomycin in the serum may be as low as 8 ,ug/ml. The usual MICs of vancomycin for methicillin-susceptible S. aureus range from 1.56 to 3.12 ,ug/ml (3). MICs and MBCs for methicillinresistant S. aureus in our laboratory are similar to those of methicillin-susceptible S. aureus, with MICs and MBCs ranging from 0.4 to 6.25 ,xg/ml. It is possible that the quantity of bioactive vancomycin was insufficient to kill the organism isolated from this patient. The vancomycin-heparin interaction probably occurred within the same intravenous tubing during administration of the compounds that were allowed to mix at high concentrations. Once concomitant administration of the two drugs through one intravenous line ceased and additional vancomycin was infused, bacteremia ceased. Unfortunately, concentrations of vancomycin were not measured in the serum when the two drugs were infused through the same line, so the precise effect of mixing the two drugs upon the bioactivity of vancomycin in the serum of our patient could not be determined.
The incompatibility of vancomycin and heparin prepared in dextrose-and-water solutions is well known. In 0.9o sodium chloride solutions, the two drugs are more compatible. It has been suggested that when the two drugs need to be administered through the same intravenous line, the solution should be prepared in 0.9% sodium chloride (8) . Because of the frequent occurrence of deep venous thrombosis and methicillin-resistant S. aureus bacteremia in the intravenous drug abuser population, care should be taken to avoid administration of heparin and vancomycin through the same intravenous line. Vancomycin, in addition, is often administered to renal dialysis patients through a heparinized fistula. Studies are planned to determine if vancomycin is inactivated in this situation.
The gradient plate assay showed no significant effect of heparin on vancomycin activity at the usual serum concentrations. No alteration in the bioactivity of vancomycin would be expected, therefore, when heparin in infused through a separate intravenous line. Once diluted in the intravascular space after separate infusion of each drug, the concentration of both drugs is much lower, in the range tested by the gradient plate assay. If necessary, infusion of the two drugs through the same line could be done serially, with a 0.9% sodium chloride solution flushing the line between the two drugs to prevent mixing at high concentration.
